Last reviewed · How we verify

trientine dihydrochloride — Competitive Intelligence Brief

trientine dihydrochloride (trientine dihydrochloride) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Copper chelator. Area: Metabolic/Genetic Disorders.

marketed Copper chelator Copper (Cu2+) Metabolic/Genetic Disorders Small molecule Live · refreshed every 30 min

Target snapshot

trientine dihydrochloride (trientine dihydrochloride) — Univar BV. Trientine is a copper chelator that binds and removes excess copper from the body, reducing copper-mediated tissue damage.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
trientine dihydrochloride TARGET trientine dihydrochloride Univar BV marketed Copper chelator Copper (Cu2+)
Syprine TRIENTINE Bausch Health marketed Copper Chelator Carbonic anhydrase 14 1985-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Copper chelator class)

  1. Univar BV · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). trientine dihydrochloride — Competitive Intelligence Brief. https://druglandscape.com/ci/trientine-dihydrochloride. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: